The use of mucolytic therapy in the treatment of infectious and inflammatory diseases of the respiratory tract-Reference-Cited by-同舟云学术

The use of mucolytic therapy in the treatment of infectious and inflammatory diseases of the respiratory tract

Published:2018-11-14 Issue:20 Volume: Page:36-42
ISSN:2079-701X
Container-title:Medical Council
language:
Short-container-title:Med. sov.

Author:

Krivopalov A. A.¹,Shamkina P. A.¹

Affiliation:

1. Saint-Petersburg Research Institute of Ear, Throat, Nose and Speech of the Ministry of Health of Russia, St. Petersburg

Abstract

The article is devoted to the use of mucolytic therapy in the treatment of infectious and inflammatory diseases of the respiratory tract. Pathogen exposure results in an increase in the viscosity and adhesion of the respiratory tract mucus and leads to an impairment of drainage function and mucociliary clearance of the bronchi. Given the pathogenetic features, the primary goal of the treatment is to change the rheological properties of sputum and remove mucus from the respiratory tract. This justifies the administration of mucolytics, taking into account their pharmacological characteristics.

Publisher

Remedium, Ltd.

Subject

General Medicine

Reference30 articles.

1. Pratter M.R. Chronic upper airway cough syndrome secondary to rhinosinus diseases (previously referred to as postnasal drip syndrome): ACCP evidence-based clinical practice guidelines. Chest, 2006, 129 (1): 63-71.

2. Nikolaeva SV, Usenko DV, Gorelov AV. New methods for the prevention of acute respiratory infections. Lechaschy Vrach, 2018, 2: 74-76.

3. Gembitskaya TE, Novikova LN, Chermensky AG. Acetylcysteine in acute and chronic respiratory diseases. Vrach, 2011, 3: 48-52.

4. Shatalina SI, Kolosova NG. Herbal remedies in the treatment of cough in children. RMJ. 2017, 19: 1371-1374.

5. Morozova SV, Svistushkin VM. Possibilities of phytotherapy in cold cough. Terapia, 2016, 1: 16-22